Michelle Renee Griffin's Net Worth

$3.43 Million

Estimate Recalculated May 20, 2025 11:47PM EST

Who is Michelle Renee Griffin

Michelle Renee Griffin has an estimated net worth of $3.43 Million. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, PHASERX, INC., Trubion Pharmaceuticals, Inc, CHINOOK THERAPEUTICS, INC., HTG MOLECULAR DIAGNOSTICS, INC, SONUS PHARMACEUTICALS INC, Acer Therapeutics Inc., DENDREON CORP, and CORIXA CORP.

SEC CIK

Michelle Renee Griffin's CIK is 0001229765

Past Insider Trading and Trends

2021 was Michelle Renee Griffin's most active year for acquiring shares with 15 total transactions. Michelle Renee Griffin's most active month to acquire stocks was the month of April. 2005 was Michelle Renee Griffin's most active year for disposing of shares, totalling 23 transactions. Michelle Renee Griffin's most active month to dispose stocks was the month of June. 2005 saw Michelle Renee Griffin paying a total of $639,499.26 for 364,974 shares, this is the most they've acquired in one year. In 2005 Michelle Renee Griffin cashed out on 729,591 shares for a total of $932,214.80, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adaptive Biotechnologies Corp

Investor
Updated Mar 06, 2024
Form 4
384.80%
79.37K
Mar 06, 2024
100.00K
Grant
Mar 04
Form 4
-10.19%
-2.34K
$8.49
-$19.88K
Mar 29, 2023
20.63K
Sale
Mar 27
Form 4
465.08%
38.10K
Mar 08, 2023
46.30K
Grant
Mar 06
Form 4
1,556.58%
23.41K
Jan 28, 2022
24.92K
Grant
Jan 26
Form 4
-21.77%
-14.92K
$21.40
-$405.72K
Aug 30, 2021
53.59K
Sale
ScheduledAug 27
Form 4
-3.52%
-2.50K
$22.30
-$72.50K
Jul 19, 2021
68.50K
Sale
ScheduledJul 14
Form 4
-5.33%
-4.00K
$23.90
-$128.80K
Jun 21, 2021
71.00K
Sale
ScheduledJun 17
Form 4
-3.23%
-2.50K
$23.18
-$76.90K
Jun 16, 2021
75.00K
Sale
ScheduledJun 14
Form 4
-3.12%
-2.50K
$21.40
-$68.00K
May 19, 2021
77.50K
Sale
ScheduledMay 18
Form 4
-5.33%
-4.50K
$25.60
-$160.24K
Apr 16, 2021
80.00K
Sale
ScheduledApr 14
Form 4
-6.63%
-6.00K
$25.43
-$211.56K
Mar 17, 2021
84.50K
Sale
ScheduledMar 15 - Mar 16
Form 4
-0.78%
-737.00
$36.44
-$343.68K
Feb 16, 2021
94.26K
Sale
ScheduledFeb 14 - Feb 16
Form 4
-5.94%
-6.00K
$36.84
-$348.45K
Jan 15, 2021
95.00K
Sale
ScheduledJan 14
Form 4
-5.61%
-6.00K
$33.32
-$306.24K
Dec 16, 2020
101.00K
Sale
ScheduledDec 14
Form 4
-5.31%
-6.00K
$27.74
-$239.33K
Nov 18, 2020
107.00K
Sale
ScheduledNov 16
Form 4
-9.60%
-12.00K
$30.32
-$540.50K
Oct 16, 2020
113.00K
Sale
ScheduledOct 14
Form 4
8.89K
Feb 18, 2020
8.89K
Grant
Feb 13
Form 3
Jun 26, 2019
Showing 18 results

PHASERX, INC.

Investor
Updated May 30, 2017
Form 4
14.00K
May 30, 2017
14.00K
Grant
May 25
Form 4
13.63K
Jun 03, 2016
13.63K
Grant
Jun 01
Form 3
May 17, 2016
Showing 3 results

Trubion Pharmaceuticals, Inc

Senior V.P. and C.O.O.
Updated Oct 28, 2010
Form 4
-100.00%
-254.23K
Oct 28, 2010
Disposition
Oct 28
Form 4
45.00K
Feb 01, 2010
45.00K
Grant
Jan 29
Form 4
27.50K
Aug 28, 2009
27.50K
Grant
Aug 27
Form 4
50.00K
Jan 30, 2009
50.00K
Grant
Jan 30
Form 4
52.00K
Mar 11, 2008
52.00K
Grant
Jan 31
Form 3
Oct 18, 2006
Showing 6 results

CHINOOK THERAPEUTICS, INC.

Investor
Updated Aug 11, 2023
Form 4
-100.00%
-46.07K
$24.85
-$1.08M
Aug 11, 2023
Disposition
Aug 11
Form 4
May 31, 2023
3.30K
Options
May 26
Form 4
16.60K
May 31, 2022
16.60K
Grant
May 26
Form 4
5.95K
Jun 07, 2021
5.95K
Grant
Jun 04
Form 4
23.52K
Oct 07, 2020
23.52K
Grant
Oct 06
Form 3
Oct 07, 2020
Showing 6 results

HTG MOLECULAR DIAGNOSTICS, INC

Investor
Updated Sep 15, 2022
Form 4
4.00K
Sep 15, 2022
4.00K
Grant
Sep 15
Form 4
4.00K
Aug 19, 2021
4.00K
Grant
Aug 18
Form 4
60.00K
Aug 21, 2020
60.00K
Grant
Aug 19
Form 4
12.50K
Aug 16, 2019
12.50K
Grant
Aug 14
Form 4
20.00K
Aug 17, 2018
20.00K
Grant
Aug 15
Form 3
Aug 17, 2018
Showing 6 results

ONCOGENEX PHARMACEUTICALS, INC.

CFO
Updated May 10, 2012
Form 4
40.00K
May 10, 2012
40.00K
Grant
May 08
Form 4
35.00K
Jan 04, 2011
35.00K
Grant
Jan 03
Form 4
3.50K
Jun 09, 2010
3.50K
Grant
Jun 08
Form 4
8.26K
$7.25
$59.89K
May 13, 2009
8.26K
Grant
May 12
Form 4
17.00K
$2.69
$45.73K
Oct 29, 2008
17.00K
Grant
Oct 28
Form 4
17.00K
May 14, 2007
17.00K
Grant
May 10
Form 4
17.00K
May 15, 2006
17.00K
Grant
May 09
Form 4
10.00K
May 24, 2005
10.00K
Grant
May 23
Form 4
15.00K
May 07, 2004
15.00K
Grant
May 05
Form 3
May 07, 2004
Showing 10 results

Acer Therapeutics Inc.

Investor
Updated Mar 16, 2023
Form 4
20.00K
Mar 16, 2023
20.00K
Grant
Mar 14
Form 4
18.50K
Jan 19, 2022
18.50K
Grant
Jan 14
Form 4
15.00K
Jan 20, 2021
15.00K
Grant
Jan 15
Form 4
9.00K
Jan 03, 2020
9.00K
Grant
Jan 02
Form 4
6.00K
Feb 05, 2019
6.00K
Grant
Feb 01
Form 4
9.00K
Oct 06, 2017
9.00K
Grant
Oct 04
Form 3
Sep 21, 2017
Showing 7 results

DENDREON CORP

CFO, SVP Fin. & Treasure
Updated Dec 15, 2005
Form 4
22.50K
Dec 15, 2005
22.50K
Grant
Dec 13
Form 4
135.00K
Aug 23, 2005
135.00K
Grant
Aug 15
Form 3
Aug 23, 2005
Showing 3 results

CORIXA CORP

Sr. Vice President, CFO
Updated Jul 14, 2005
Form 4
-100.00%
-532.12K
$3.82
-$292.72K
Jul 14, 2005
Options
Jul 12
Form 4
150.00K
$3.95
$592.50K
Jan 03, 2005
150.00K
Grant
Dec 15
Form 4
40.50K
$6.04
$244.62K
Jan 05, 2004
40.50K
Grant
Dec 31
Showing 3 results